Visual percepts evoked with an intracortical 96-channel microelectrode array inserted in human occipital cortex.


Journal

The Journal of clinical investigation
ISSN: 1558-8238
Titre abrégé: J Clin Invest
Pays: United States
ID NLM: 7802877

Informations de publication

Date de publication:
01 12 2021
Historique:
received: 11 05 2021
accepted: 28 09 2021
pubmed: 20 10 2021
medline: 11 1 2022
entrez: 19 10 2021
Statut: ppublish

Résumé

BACKGROUNDA long-held goal of vision therapy is to transfer information directly to the visual cortex of blind individuals, thereby restoring a rudimentary form of sight. However, no clinically available cortical visual prosthesis yet exists.METHODSWe implanted an intracortical microelectrode array consisting of 96 electrodes in the visual cortex of a 57-year-old person with complete blindness for a 6-month period. We measured thresholds and the characteristics of the visual percepts elicited by intracortical microstimulation.RESULTSImplantation and subsequent explantation of intracortical microelectrodes were carried out without complications. The mean stimulation threshold for single electrodes was 66.8 ± 36.5 μA. We consistently obtained high-quality recordings from visually deprived neurons and the stimulation parameters remained stable over time. Simultaneous stimulation via multiple electrodes was associated with a significant reduction in thresholds (P < 0.001, ANOVA) and evoked discriminable phosphene percepts, allowing the blind participant to identify some letters and recognize object boundaries.CONCLUSIONSOur results demonstrate the safety and efficacy of chronic intracortical microstimulation via a large number of electrodes in human visual cortex, showing its high potential for restoring functional vision in the blind.TRIAL REGISTRATIONClinicalTrials.gov identifier NCT02983370.FUNDINGThe Spanish Ministerio de Ciencia Innovación y Universidades, the Generalitat Valenciana (Spain), the Europan Union's Horizon 2020 programme, the Bidons Egara Research Chair of the University Miguel Hernández (Spain), and the John Moran Eye Center of the University of Utah.

Identifiants

pubmed: 34665780
pii: 151331
doi: 10.1172/JCI151331
pmc: PMC8631600
doi:
pii:

Banques de données

ClinicalTrials.gov
['NCT02983370']

Types de publication

Case Reports Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NINDS NIH HHS
ID : K23 NS114178
Pays : United States

Commentaires et corrections

Type : CommentIn

Références

Artif Organs. 2003 Nov;27(11):1005-15
pubmed: 14616519
J Neural Eng. 2012 Apr;9(2):026002
pubmed: 22306622
Brain Res Brain Res Protoc. 2002 Oct;10(2):115-24
pubmed: 12431711
Ann Biomed Eng. 2002 Jan;30(1):107-19
pubmed: 11874134
Bioelectron Med. 2018 Aug 13;4:12
pubmed: 32232088
Biomed Microdevices. 2009 Apr;11(2):453-66
pubmed: 19067174
Brain. 1996 Apr;119 ( Pt 2):507-22
pubmed: 8800945
Biomed Mater. 2010 Feb;5(1):15007
pubmed: 20124668
J Neural Eng. 2009 Jun;6(3):035001
pubmed: 19458403
Invest Ophthalmol Vis Sci. 2006 Mar;47(3):1241-50
pubmed: 16505065
Nature. 2021 May;593(7858):249-254
pubmed: 33981047
Neuroimage. 2010 Jan 15;49(2):1171-9
pubmed: 19800409
Int J Neural Syst. 2020 Sep;30(9):2050045
pubmed: 32689842
Curr Biol. 2019 Mar 18;29(6):1019-1029.e4
pubmed: 30853432
Science. 2020 Dec 4;370(6521):1191-1196
pubmed: 33273097
Retina. 2009 Nov-Dec;29(10):1513-21
pubmed: 19730162
Science. 2015 May 22;348(6237):906-10
pubmed: 25999506
Nature. 1976 Jan 15;259(5539):111-2
pubmed: 1246346
J Neural Eng. 2016 Apr;13(2):021001
pubmed: 26792176
Eye (Lond). 2012 Jan;26(1):101-8
pubmed: 21997359
Neuromodulation. 2020 Jun;23(4):411-426
pubmed: 31747103
IEEE Trans Biomed Eng. 2021 Jul;68(7):2313-2325
pubmed: 33784612
J Neural Eng. 2005 Dec;2(4):R1-12
pubmed: 16317227
Neuromodulation. 2017 Dec;20(8):745-752
pubmed: 29076214
J Neurosurg. 2019 May 31;132(6):2000-2007
pubmed: 31151104
Front Neurosci. 2020 Aug 11;14:681
pubmed: 32848535
Hear Res. 1994 Jun 15;77(1-2):105-15
pubmed: 7928722
J Physiol. 1968 May;196(2):479-93
pubmed: 4871047
Cell. 2020 May 14;181(4):774-783.e5
pubmed: 32413298
IEEE Trans Biomed Eng. 1992 Apr;39(4):424-6
pubmed: 1592409
Nat Methods. 2020 Mar;17(3):261-272
pubmed: 32015543
Int J Neural Syst. 2018 Dec;28(10):1850043
pubmed: 30556459
Med Biol Eng Comput. 1990 May;28(3):257-9
pubmed: 2377008
J Neurosci. 2013 Oct 9;33(41):16209-19
pubmed: 24107953
Ann Biomed Eng. 1992;20(4):439-49
pubmed: 1510295
Nature. 2016 Apr 13;533(7602):247-50
pubmed: 27074513
Int J Neural Syst. 2016 Nov;26(7):1650021
pubmed: 27354187
J Neural Eng. 2020 Oct 31;17(5):056042
pubmed: 33045689
Neuroscience. 2001;105(1):19-31
pubmed: 11483297
Nat Clin Pract Neurol. 2007 Aug;3(8):444-52
pubmed: 17671522
Hum Neurobiol. 1982;1(4):281-3
pubmed: 7185798
Cell. 2020 May 14;181(4):758-759
pubmed: 32413296
J Physiol. 1974 Dec;243(2):553-76
pubmed: 4449074
Front Neurol Neurosci. 2018;41:117-124
pubmed: 29145190
Curr Biol. 2012 Nov 6;22(21):2081-5
pubmed: 23041195
Neuron. 2017 Jul 5;95(1):209-220.e3
pubmed: 28625487
Biosystems. 2007 Feb;87(2-3):156-63
pubmed: 17011701
J Neurosci. 2017 Jul 26;37(30):7188-7197
pubmed: 28652411
Neuron. 2016 Dec 21;92(6):1213-1219
pubmed: 27939584
Front Neuroeng. 2010 May 28;3:8
pubmed: 20577634
Sci Transl Med. 2016 Oct 19;8(361):361ra141
pubmed: 27738096
J Neural Eng. 2016 Dec;13(6):061003
pubmed: 27762237
IEEE Trans Biomed Eng. 2012 Nov;59(11):3255-62
pubmed: 22922687
Science. 1974 Feb 1;183(4123):440-4
pubmed: 4808973

Auteurs

Eduardo Fernández (E)

Bioengineering Institute and Cátedra Bidons Egara, University Miguel Hernández, Elche, Spain.
CIBER Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER BBN), Madrid, Spain.
John Moran Eye Center and Biomedical Engineering, University of Utah, Salt Lake City, Utah, USA.

Arantxa Alfaro (A)

Bioengineering Institute and Cátedra Bidons Egara, University Miguel Hernández, Elche, Spain.
CIBER Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER BBN), Madrid, Spain.
Servicio de Neurología, Hospital Vega Baja, Orihuela, Spain.

Cristina Soto-Sánchez (C)

Bioengineering Institute and Cátedra Bidons Egara, University Miguel Hernández, Elche, Spain.
CIBER Research Center on Bioengineering, Biomaterials and Nanomedicine (CIBER BBN), Madrid, Spain.

Pablo Gonzalez-Lopez (P)

Bioengineering Institute and Cátedra Bidons Egara, University Miguel Hernández, Elche, Spain.
Servicio de Neurocirugía, Hospital Universitario de Alicante, Alicante, Spain.

Antonio M Lozano (AM)

Bioengineering Institute and Cátedra Bidons Egara, University Miguel Hernández, Elche, Spain.

Sebastian Peña (S)

Bioengineering Institute and Cátedra Bidons Egara, University Miguel Hernández, Elche, Spain.

Maria Dolores Grima (MD)

Bioengineering Institute and Cátedra Bidons Egara, University Miguel Hernández, Elche, Spain.

Alfonso Rodil (A)

Bioengineering Institute and Cátedra Bidons Egara, University Miguel Hernández, Elche, Spain.

Bernardeta Gómez (B)

Bioengineering Institute and Cátedra Bidons Egara, University Miguel Hernández, Elche, Spain.

Xing Chen (X)

Department of Vision & Cognition, Netherlands Institute for Neuroscience, Amsterdam, Netherlands.

Pieter R Roelfsema (PR)

Department of Vision & Cognition, Netherlands Institute for Neuroscience, Amsterdam, Netherlands.
Department of Integrative Neurophysiology, Center for Neurogenomics and Cognitive Resarch, VU University, and Department of Psychiatry, Academic Medical Center, Amsterdam, Netherlands.

John D Rolston (JD)

Departments of Neurosurgery and Biomedical Engineering, University of Utah, Salt Lake City, Utah, USA.

Tyler S Davis (TS)

John Moran Eye Center and Biomedical Engineering, University of Utah, Salt Lake City, Utah, USA.
Departments of Neurosurgery and Biomedical Engineering, University of Utah, Salt Lake City, Utah, USA.

Richard A Normann (RA)

John Moran Eye Center and Biomedical Engineering, University of Utah, Salt Lake City, Utah, USA.
Departments of Neurosurgery and Biomedical Engineering, University of Utah, Salt Lake City, Utah, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH